Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» FTC
FTC
FTC says patent battle over Parkinson's drug could have 'significant implications' for patients
FTC says patent battle over Parkinson's drug could have 'significant implications' for patients
Endpoints
FTC
Parkinson's Disease
Apokyn
Supernus Pharmaceuticals
Sage Chemical
patents
Flag link:
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
BioPharma Dive
FTC
Pfizer
Seagen
M&A
antitrust
anticompetitive practices
Flag link:
US deal watchdog's bark could be worse than its bite
US deal watchdog's bark could be worse than its bite
EP Vantage
M&A
FTC
Flag link:
FTC's Non-Compete Law Could Propel Rise in Trade Secrets Lawsuits
FTC's Non-Compete Law Could Propel Rise in Trade Secrets Lawsuits
BioSpace
FTC
non-compete
trade secrets
legal
Flag link:
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Fierce Pharma
Elizabeth Warren
Senate
FTC
M&A
Amgen
Horizon Therapeutics
Indivior
Opiant Pharmaceuticals
Flag link:
Martin Shkreli runs afoul of FTC for potentially skirting lifetime pharmaceutical industry ban
Martin Shkreli runs afoul of FTC for potentially skirting lifetime pharmaceutical industry ban
Fierce Pharma
Martin Shkreli
FTC
Druglike
Flag link:
Pharma’s digital marketing in crosshairs, as FTC’s plan to curb ‘commercial surveillance’ gains steam
Pharma’s digital marketing in crosshairs, as FTC’s plan to curb ‘commercial surveillance’ gains steam
Medical Marketing and Media
FTC
pharma marketing
digital marketing
surveillance marketing
Flag link:
In Jazz case, FTC urges court to delist patent on blockbuster Xyrem
In Jazz case, FTC urges court to delist patent on blockbuster Xyrem
Fierce Pharma
Jazz Pharma
FTC
Xyrem
narcolepsy
legal
Flag link:
FTC Amicus Brief Challenges Abuse of FDA “Orange Book” Listing Procedures to Block Drug Competition
FTC Amicus Brief Challenges Abuse of FDA “Orange Book” Listing Procedures to Block Drug Competition
FTC
legal
FTC
Orange Book
Jazz Pharmaceuticals
Avadel Pharma
patents
competition
Flag link:
EU swats down Illumina's $8B Grail acquisition days after FTC lost antitrust case
EU swats down Illumina's $8B Grail acquisition days after FTC lost antitrust case
Endpoints
Europe
Illumina
Grail
FTC
M&A
Flag link:
Illumina defeats F.T.C. in major antitrust case
Illumina defeats F.T.C. in major antitrust case
NY Times, NY
Illumina
FTC
Grail
M&A
antitrust
Flag link:
FTC Unanimously Agrees to Keep Close Eye on PBMs, Higher Drug Costs
FTC Unanimously Agrees to Keep Close Eye on PBMs, Higher Drug Costs
BioSpace
FTC
PBMs
drug pricing
Flag link:
Pharma under the microscope as FTC considers new ways to review acquisitions
Pharma under the microscope as FTC considers new ways to review acquisitions
BioPharma Dive
FTC
M&A
Flag link:
FTC targets insulin, threatening to go after PBM-pharma deals that steer into 'commercial bribery'
FTC targets insulin, threatening to go after PBM-pharma deals that steer into 'commercial bribery'
Endpoints
FTC
insulin
diabetes
drug pricing
PBMs
Flag link:
Did J&J and BMS conspire on blood thinner price hikes? Congressional leaders want DOJ, FTC to look into it: report
Did J&J and BMS conspire on blood thinner price hikes? Congressional leaders want DOJ, FTC to look into it: report
Fierce Pharma
JNJ
Xarelto
Bristol Myers Squibb
Eliquis
drug pricing
blood thinners
FTC
Flag link:
FTC launches probe into pharmacy benefit management sector
FTC launches probe into pharmacy benefit management sector
Pharmaforum
FTC
PBMs
drug pricing
Flag link:
Pile-on over PBMs continues with FTC comments and a new bipartisan Senate bill
Pile-on over PBMs continues with FTC comments and a new bipartisan Senate bill
Endpoints
FTC
PBMs
regulatory
Senate
Flag link:
Medtronic Hits an FTC Roadblock in Intersect ENT Deal
Medtronic Hits an FTC Roadblock in Intersect ENT Deal
Medical Devices and Diagnostics Industry
Medtech
devices
Medtronic
FTC
M&A
Intersect ENT
Flag link:
FTC deadlocks on vote to launch study into PBM practices
FTC deadlocks on vote to launch study into PBM practices
BioPharma Dive
FTC
PBMs
drug pricing
Flag link:
FTC plots a look into the competitive impact of PBMs on drug prices, pharmacies
FTC plots a look into the competitive impact of PBMs on drug prices, pharmacies
Endpoints
FTC
PBMs
drug pricing
competition
Flag link:
Pages
1
2
3
4
5
6
7
8
9
next ›
last »